Sectors
FDA Approves Eli Lilly's Alzheimer’s Drug Donanemab, Expanding US Treatment Options
The FDA has approved Eli Lilly’s Alzheimer’s drug donanemab, branded as Kisunla, for early symptomatic adults, providing a new treatment option for nearly 7 million Americans affected by the disease.
Apple Joins OpenAI's Board: Phil Schiller Takes Observer Role in Historic Partnership
Apple has secured an observer role on OpenAI’s board as part of a significant agreement, with Phil Schiller, the head of Apple’s App Store, appointed to the position.
US Crude Oil Price Surges Due to Middle East Tensions and Hurricane Beryl
Escalating geopolitical tensions between Israel and Hezbollah and Hurricane Beryl's potential impact on Gulf Coast refineries push US crude oil prices to reach a two-month high.
Moderna Receives $176 Million US Grant for Bird Flu Vaccine Development
Moderna received $176 million from the US government to fast-track the development of its bird flu vaccine, following the spread of the H5N1 virus in dairy herds across multiple states.